Scalper1 News
A lot of drug companies outsource parts of their operations — manufacturing, for instance, or running clinical trials. Back in 2007, Francois Nader had a more radical idea: What if you outsource everything? Nader was an executive at NPS Pharmaceuticals (NPSP), and the company was in dire straits after failing to win U.S. approval for its osteoporosis drug Preos, even though Europe accepted it. To save the company financially, he proposed selling Scalper1 News
Scalper1 News